Presentation...Non-surgical management of brain tumors
Targeting angiogenesis in Lung cance r Lucio Crinò, MD Medical Oncology Department University Hospital Perugia, Italy.
The Combination of Bevacizumab (Bev) with capecitabine/irinotecan (CapIri/Bev) or capecitabine/oxaliplatin (CapOx/Bev) is highly active in advanced colorectal.
FOLFOX4 with or without Bevacizumab in Previously Treated Advanced Colorectal Cancer: Results from ECOG-E3200 Lee M Ellis, MD Colorectal Cancer Update.